C07J 73/008
Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of
Official title: {by two hetero atoms}
C07J73/008 (Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of) appears on 7 US grants and 12 published applications in this corpus.
Search patents in C07J- Granted patents
- 7
- Published applications
- 12
- Assignees
- 9
- Inventors
- 40
- Latest grant
- 5 Dec 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 0 | 1 |
| 2012 | 0 | 1 |
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 2 | 2 |
| 2016 | 0 | 0 |
| 2017 | 0 | 1 |
| 2018 | 2 | 0 |
| 2019 | 0 | 1 |
| 2020 | 1 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 1 |
| 2023 | 1 | 0 |
| 2024 | 0 | 1 |
| 2025 | 0 | 1 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Anti-cancer nuclear hormone receptor-targeting compounds5 Dec 2023US 11,834,458 B2Nuvation Bio Inc.
- Complex and structurally diverse compounds13 Oct 2020US 10,800,730 B2The Board of Trustees of the University of Illinois
- Complex and structurally diverse compounds25 Sep 2018US 10,081,592 B2The Board of Trustees of the University of Illinois
- Limonin extraction method20 Feb 2018US 9,896,477 B2Jimei University
- Control of flavor characteristics of and indicator of freshness in fruit juice17 Mar 2015US 8,980,352 B2Tropicana Products, Inc.
- Anti-cancer nuclear hormone receptor-targeting compounds30 Apr 2026US 2026/0116890 A1Nuvation Bio Inc.
- Pharmaceutical Compounds, Pharmaceutical compositions, and methods of treating hair loss and other disorders27 Mar 2025US 2025/0101060 A1Miralogx LLC
- Anti-cancer nuclear hormone receptor-targeting compounds24 Oct 2024US 2024/0352027 A1Nuvation Bio Inc.
- Anti-cancer nuclear hormone receptor-targeting compounds27 Oct 2022US 2022/0340587 A1Nuvation Bio Inc.
- Complex and structurally diverse compounds23 May 2019US 2019/0152891 A1The Board of Trustees of the University of Illinois
Most cited
By later US patents